Gut bacteria hold the key to infant liver development and drug metabolism

July 30, 2015, Hebrew University of Jerusalem
Stem cell-derived hepatocytes emerging. Credit: Yaakov Nahmias / Hebrew University

The liver plays a critical role in human metabolism. As the gatekeeper of the digestive track, this massive organ is responsible for drug breakdown and is therefore the first to be injured due to overdose or misuse. Evaluating this drug-induced liver injury is a critical part of pharmaceutical drug discovery and must be carried out on human liver cells. Regretfully, human liver cells, called hepatocytes, are in scarce supply as they can only be isolated from donated organs.

Now, in research published on the cover of the July edition of Hepatology, scientists from the Hebrew University of Jerusalem's Alexander Grass Center for Bioengineering report that they produced large amounts of functional from human embryonic and genetic engineered stem cells.

"This is quite a revolution for pharmaceutical drug discovery," said Prof. Yaakov Nahmias, the study's senior author. "While other groups have been able to produce liver cells before us, their cells showed little functional activity, and could not be reliably used for drug discovery. In fact, up until now stem cell-derived hepatocytes showed little ability to predict clinical outcome."

The limited availability of functional hepatocytes for drug testing is a major bottleneck bringing pharmaceutical companies to spend $1 billion/year on liver cells alone. "Our ability to produce an unlimited supply of functional liver cells from human can change all that," said Nahmias.

The breakthrough came with the birth of Nahmias' baby girl earlier this year. "I watched her feeding just moments after birth, and realized this is the first time her liver started working," said Nahmias. "Nobody had thought of mimicking this part of human development before, so that's exactly what we did."

The team went on to discover that the bacteria populating the infant gut moments after birth produce vitamin K2 and bile acids that activate the fetal liver's dormant drug metabolism program.

The groundbreaking work further demonstrated that liver cells produced from either embryonic or genetically engineered , can detect the toxic effect of over a dozen drugs with greater than 97% accuracy.

"The implications for liver biology and are quite staggering," said Prof. Oren Shibolet, Head of the Liver Unit at the Tel-Aviv Sourasky Medical Center, who was not involved in this study. "The method provides access to unlimited amounts of functional liver cells and is likely to critically improve our ability to predict drug toxicity, which was previously limited by the unavailability of liver cells. Furthermore, as gut bacteria develop differently in infants delivered by caesarean section, the mode of delivery can possibly affect newborns' liver maturation. Current practice is to routinely administer Vitamin K to newborns. The data presented suggest that parents abstaining from this practice may cause liver maturation and drug metabolism in their children to develop quiet differently."

Other co-authors participating in the study include Yishai Avior, Gahl Levy, Michal Zimerman, Dr. Danny Kitsberg, Dr. Ronen Sadeh, Dr. Arieh Moussaieff, Dr. Merav Cohen, Prof. Robert Schwartz from the Weill Cornell Medical College, and Prof. Joseph Itskovitz-Eldor from the Rambam Medical Center.

The work was funded by the European Research Council, the British Council BIRAX Regenerative Medicine initiative, and the HeMibio consortium funded by the European Commission and Cosmetics Europe as part of the SEURAT-1 cluster.

Explore further: Researchers using ground-breaking stem cell technology to test and assess new approaches to disease

Related Stories

Researchers using ground-breaking stem cell technology to test and assess new approaches to disease

July 21, 2015
Scientists have successfully used stem cells to grow fully functional bile ducts in the lab, which could one day help prevent liver tissue damage. Bile ducts are vital to enabling the liver to dispose of waste; malfunctioning ...

Isolation and characterization of human hepatocytes and non-parenchymal liver cells

June 17, 2015
University Medicine Berlin, Department for General, Visceral and Transplantation Surgery, led by Dr. Georg Damm (and Prof. Dr. Daniel Seehofer) have established a protocol for an uncomplicated isolation of primary human hepatocytes ...

Cystic fibrosis treatment tested on lab-grown bile ducts

July 14, 2015
An experimental cystic fibrosis drug has been shown prevent the disease's damage to the liver, thanks to a world-first where scientists grew mini bile ducts in the lab.

Stem cells reach standard for use in drug development

June 11, 2013
Drug development for a range of conditions could be improved with stem cell technology that helps doctors predict the safety and the effectiveness of potential treatments.

A master gene determines whether cells become pancreatic or liver cells

July 15, 2015
A gene in human embryonic stem cells not only steers them to form a pancreas but simultaneously prevents them from becoming liver cells, A*STAR researchers have shown. This discovery is an important step toward growing functioning ...

Researchers test bioartificial liver device to treat acute liver failure

July 24, 2015
Approximately 30,000 to 40,000 people die from liver disease each year, according to the American Liver Foundation. For people who experience acute liver failure, the only proven treatment has been liver transplantation. ...

Recommended for you

Japanese team creates human oogonia using human stem cells in artificial mouse ovaries

September 21, 2018
A team of researchers with members from several institutions in Japan has successfully generated human oogonia inside of artificial mouse ovaries using human stem cells. In their paper published in the journal Science, the ...

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

A Trojan Horse delivery for treating a rare, potentially deadly, blood-clotting disorder

September 21, 2018
In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. The researchers deliver this therapeutic ...

Researchers explore how changes in diet alter microbiome in artificial intestine

September 21, 2018
Using an artificial intestine they created, researchers have shown that the microbiome can quickly adapt from the bacterial equivalent of a typical western diet to one composed exclusively of dietary fats. That adaptation ...

Study identifies stem cell that gives rise to new bone and cartilage in humans

September 20, 2018
A decade-long effort led by Stanford University School of Medicine scientists has been rewarded with the identification of the human skeletal stem cell.

Scientists grow human esophagus in lab

September 20, 2018
Scientists working to bioengineer the entire human gastrointestinal system in a laboratory now report using pluripotent stem cells to grow human esophageal organoids.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.